Francesco Merli

9.9k total citations · 2 hit papers
157 papers, 4.3k citations indexed

About

Francesco Merli is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Francesco Merli has authored 157 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Pathology and Forensic Medicine, 66 papers in Oncology and 45 papers in Genetics. Recurrent topics in Francesco Merli's work include Lymphoma Diagnosis and Treatment (115 papers), Viral-associated cancers and disorders (40 papers) and Chronic Lymphocytic Leukemia Research (39 papers). Francesco Merli is often cited by papers focused on Lymphoma Diagnosis and Treatment (115 papers), Viral-associated cancers and disorders (40 papers) and Chronic Lymphocytic Leukemia Research (39 papers). Francesco Merli collaborates with scholars based in Italy, United States and France. Francesco Merli's co-authors include Stefano Luminari, Caterina Stelitano, Massimo Federico, Umberto Vitolo, Luigi Rigacci, Luigi Marcheselli, Francesco Di Raimondo, Paolo G. Gobbi, Emilio Iannitto and Alessandro Levis and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Francesco Merli

152 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early Interim 2-[ ¹⁸ F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study

2007 552 citations Andrea Gallamini, Martin Hutchings et al. Journal of Clinical Oncology profile →
Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

2009 506 citations Massimo Federico, Monica Bellei et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Francesco Merli Italy	33	3.4k	1.8k	1.2k	1.0k	912	157	4.3k
Caterina Stelitano Italy	32	3.0k 0.9×	1.4k 0.8×	1.3k 1.1×	851 0.8×	632 0.7×	114	3.8k
Stefano Luminari Italy	35	4.3k 1.3×	2.6k 1.4×	1.3k 1.1×	1.1k 1.1×	953 1.0×	216	5.6k
Christophe Fermé France	26	3.7k 1.1×	2.4k 1.3×	1.3k 1.1×	617 0.6×	370 0.4×	98	4.3k
Lars Møller Pedersen Denmark	28	2.1k 0.6×	1.4k 0.8×	564 0.5×	586 0.6×	705 0.8×	103	3.4k
Matthew J. Matasar United States	32	2.7k 0.8×	2.4k 1.3×	897 0.8×	353 0.4×	567 0.6×	190	3.9k
Judith Trotman Australia	27	2.7k 0.8×	1.3k 0.7×	592 0.5×	576 0.6×	738 0.8×	159	3.6k
Catherine Sebban France	24	2.3k 0.7×	1.8k 1.0×	575 0.5×	405 0.4×	332 0.4×	68	3.0k
Ralph Naumann Germany	21	1.6k 0.5×	986 0.5×	604 0.5×	588 0.6×	819 0.9×	52	2.9k
Fabrice Jardin France	37	2.6k 0.8×	1.8k 1.0×	500 0.4×	548 0.5×	505 0.6×	217	4.4k
Dok Hyun Yoon South Korea	35	2.1k 0.6×	2.4k 1.3×	541 0.5×	785 0.8×	288 0.3×	303	4.3k

Countries citing papers authored by Francesco Merli

Since Specialization

Citations

This map shows the geographic impact of Francesco Merli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Merli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Merli more than expected).

Fields of papers citing papers by Francesco Merli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Merli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Merli. The network helps show where Francesco Merli may publish in the future.

Co-authorship network of co-authors of Francesco Merli

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Merli. A scholar is included among the top collaborators of Francesco Merli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Merli. Francesco Merli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zedde, Marialuisa, Micol Quaresima, Isabella Capodanno, et al.. (2024). Neurovascular Manifestations of Sickle Cell Disease. SHILAP Revista de lepidopterología. 5(3). 277–320. 2 indexed citations

Penna, Domenico, Alessia Tieghi, Riccardo Valli, & Francesco Merli. (2023). Ruxolitinib: a new first-line strategy in autoimmune myelofibrosis treatment. Leukemia & lymphoma. 64(10). 1723–1726.

Guberti, Monica, Stefano Botti, Luisa Savoldi, et al.. (2022). Efficacy and safety of a colostrum- and Aloe vera-based oral care protocol to prevent and treat severe oral mucositis in patients undergoing hematopoietic stem cell transplantation: a single-arm phase II study. Annals of Hematology. 101(10). 2325–2336. 3 indexed citations

Rocco, Alice Di, Antonio Cuneo, Arianna Di Rocco, et al.. (2020). Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapy. Leukemia & lymphoma. 62(4). 828–836. 12 indexed citations

Luminari, Stefano, Benedetta Donati, Massimiliano Casali, et al.. (2019). A Gene Expression–based Model to Predict Metabolic Response After Two Courses of ABVD in Hodgkin Lymphoma Patients. Clinical Cancer Research. 26(2). 373–383. 11 indexed citations

Capodanno, Isabella, et al.. (2018). Home Care of Acute Leukemia Patients: From Active Therapy to End-of-Life and Palliative Care. a Three-Year Experience of a Single Centre. Blood. 132(Supplement 1). 5867–5867.

Foss, Francine M., Steven M. Horwitz, Monica Bellei, et al.. (2017). Outcome of Patients with Gamma Delta T Cell Lymphomas: Analysis of 1429 Cases Registered in the Prospective T-Cell Project. Blood. 130. 1512–1512. 3 indexed citations

Frazzi, Raffaele, Eleonora Zanetti, Mariaelena Pistoni, et al.. (2017). Methylation changes of SIRT1, KLF4, DAPK1 and SPG20 in B-lymphocytes derived from follicular and diffuse large B-cell lymphoma. Leukemia Research. 57. 89–96. 27 indexed citations

Zallio, Francesco, Stefania Tamiazzo, Chiara Monagheddu, et al.. (2016). Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL). British Journal of Haematology. 172(6). 879–888. 19 indexed citations

10.

Maurer, Matthew J., Thomas M. Habermann, Qian Shi, et al.. (2016). Utility of Progression-Free Survival at 24 Months (PFS24) to Predict Subsequent Outcome for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Enrolled on Randomized Clinical Trials: Findings from a Surrogate Endpoint in Aggressive Lymphoma (SEAL) Analysis of Individual Patient Data from 5853 Patients. Blood. 128(22). 3027–3027. 5 indexed citations

11.

Rossi, Davide, Alessio Bruscaggin, Sara Galimberti, et al.. (2015). The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study. Haematologica. 100(4). 517–524. 4 indexed citations

12.

Rigacci, Luigi, Benedetta Puccini, Pier Luigi Zinzani, et al.. (2015). The prognostic value of positron emission tomography performed after two courses (INTERIM‐PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL). American Journal of Hematology. 90(6). 499–503. 27 indexed citations

13.

Merli, Francesco, Stefano Luminari, Giuseppe Rossi, et al.. (2013). Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi. Leukemia & lymphoma. 55(1). 38–43. 56 indexed citations

14.

Luminari, Stefano, Irène Biasoli, Luca Arcaini, et al.. (2013). The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi. Annals of Oncology. 24(8). 2108–2112. 110 indexed citations

15.

Gobbi, Paolo G., et al.. (2012). Tumour burden at diagnosis as the main clinical predictor of cell resistance in patients with early stage, favourable Hodgkin lymphoma treated with VBM chemotherapy plus radiotherapy. Hematological Oncology. 31(3). 151–155. 8 indexed citations

16.

Merli, Francesco, Stefano Luminari, Fiorella Ilariucci, et al.. (2008). Rituximab Plus Hypercvad Alternating with High Dose Methotrexate and Cytarabine for Patients with Newly Diagnosed Mantle Cell Lymphoma. A Multicenter Trial from GISL. Blood. 112(11). 3050–3050. 6 indexed citations

17.

Merli, Francesco, Xiaodong Wang, & Giorgio M. Vitetta. (2008). A Bayesian Multiuser Detection Algorithm for MIMO-ODFM Systems Affected by Multipath Fading, Carrier Frequency Offset, and Phase Noise. IEEE Journal on Selected Areas in Communications. 26(3). 506–516. 19 indexed citations

18.

Gallamini, Andrea, Martin Hutchings, Luigi Rigacci, et al.. (2007). Early Interim 2-[ ¹⁸ F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study. Journal of Clinical Oncology. 25(24). 3746–3752. 552 indexed citations breakdown →

19.

Vallisa, Daniele, Luigi Cavanna, Raffaella Bertè, et al.. (1995). Autoimmune Thyroid Dysfunctions in Hematologic Malignancies Treated with Alpha-lnterferon. Acta Haematologica. 93(1). 31–35. 16 indexed citations

20.

Narni, Franco, Maria Mariano, Francesco Merli, et al.. (1989). T‐cell receptor genes expression in B‐cell leukaemias. British Journal of Haematology. 72(3). 343–349. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact